Integrated Diagnostics Holdings (FRA:8I8) Piotroski F-Score: N/A (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8I8 Integrated Diagnostics Holdings PLC FRA:8I8
56 GF Score
Price €0.41
GF Value €0.46
! 4 Warning Signs
View Full Analysis

What is Integrated Diagnostics Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Integrated Diagnostics Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Integrated Diagnostics Holdings's Piotroski F-Score or its related term are showing as below:

During the past 13 years, the highest Piotroski F-Score of Integrated Diagnostics Holdings was 8. The lowest was 1. And the median was 6.

Integrated Diagnostics Holdings  (FRA:8I8) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Integrated Diagnostics Holdings Piotroski F-Score Related Terms


Integrated Diagnostics Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Integrated Diagnostics Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings Piotroski F-Score Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 4.00 6.00 8.00 8.00

Integrated Diagnostics Holdings Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 5.00 6.00 7.00

FRA:8I8 vs TMO, DHR, NTRA: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Piotroski F-Score falls into.


FRA:8I8
56GF Score
Integrated Diagnostics Holdings PLC FRA:8I8
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Net Income was 5.2882985770882 + 3.2785208824867 + 10.840547673139 + 2.2046530107035 = €21.61 Mil.
Cash Flow from Operations was 8.4072982273185 + 4.7086152192919 + 2.3578089945422 + 5.8869063847492 = €21.36 Mil.
Revenue was 35.150503165516 + 32.170529426545 + 30.387971903862 + 25.899833488736 = €123.61 Mil.
Gross Profit was 13.986095066863 + 11.345202247019 + 10.869830453716 + 9.4704852812241 = €45.67 Mil.
Average Total Assets from the begining of this year (Jun23)
to the end of this year (Jun24) was
(162.26789353314 + 175.12790240063 + 168.99406020138 + 126.73827941866 + 131.49228664672) / 5 = €152.92408444 Mil.
Total Assets at the begining of this year (Jun23) was €162.27 Mil.
Long-Term Debt & Capital Lease Obligation was €1.05 Mil.
Total Current Assets was €52.78 Mil.
Total Current Liabilities was €33.17 Mil.
Net Income was -0.94301453739126 + 5.8284131293876 + 5.3507746542586 + 1.5068226863317 = €11.74 Mil.

Revenue was 43.881392020339 + 34.216819326689 + 28.324239247645 + 28.442679301946 = €134.87 Mil.
Gross Profit was 17.722201939585 + 11.508390425845 + 9.734282345154 + 9.6224250013839 = €48.59 Mil.
Average Total Assets from the begining of last year (Jun22)
to the end of last year (Jun23) was
(320.30989403932 + 260.31961261205 + 200.46575909833 + 166.37511781789 + 162.26789353314) / 5 = €221.94765542 Mil.
Total Assets at the begining of last year (Jun22) was €320.31 Mil.
Long-Term Debt & Capital Lease Obligation was €2.36 Mil.
Total Current Assets was €50.47 Mil.
Total Current Liabilities was €39.01 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Integrated Diagnostics Holdings's current Net Income (TTM) was 21.61. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Integrated Diagnostics Holdings's current Cash Flow from Operations (TTM) was 21.36. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun23)
=21.612020143417/162.26789353314
=0.13318728

ROA (Last Year)=Net Income/Total Assets (Jun22)
=11.742995932587/320.30989403932
=0.03666136

Integrated Diagnostics Holdings's return on assets of this year was 0.13318728. Integrated Diagnostics Holdings's return on assets of last year was 0.03666136. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Integrated Diagnostics Holdings's current Net Income (TTM) was 21.61. Integrated Diagnostics Holdings's current Cash Flow from Operations (TTM) was 21.36. ==> 21.36 <= 21.61 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=1.0484855098679/152.92408444
=0.00685625

Gearing (Last Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=2.3599975082983/221.94765542
=0.01063313

Integrated Diagnostics Holdings's gearing of this year was 0.00685625. Integrated Diagnostics Holdings's gearing of last year was 0.01063313. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun24)=Total Current Assets/Total Current Liabilities
=52.780887227343/33.169359345573
=1.59125435

Current Ratio (Last Year: Jun23)=Total Current Assets/Total Current Liabilities
=50.471079945064/39.014769265452
=1.29364035

Integrated Diagnostics Holdings's current ratio of this year was 1.59125435. Integrated Diagnostics Holdings's current ratio of last year was 1.29364035. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Integrated Diagnostics Holdings's number of shares in issue this year was 600. Integrated Diagnostics Holdings's number of shares in issue last year was 600. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=45.671613048822/123.60883798466
=0.36948501

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=48.587299711968/134.86512989662
=0.36026584

Integrated Diagnostics Holdings's gross margin of this year was 0.36948501. Integrated Diagnostics Holdings's gross margin of last year was 0.36026584. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun23)
=123.60883798466/162.26789353314
=0.76175783

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun22)
=134.86512989662/320.30989403932
=0.42104578

Integrated Diagnostics Holdings's asset turnover of this year was 0.76175783. Integrated Diagnostics Holdings's asset turnover of last year was 0.42104578. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Integrated Diagnostics Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Is Integrated Diagnostics Holdings (FRA:8I8) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued. The current stock price of €0.41 is trading 10% below its estimated GF Value™ of €0.46.

Key valuation signals for FRA:8I8:

  • Piotroski F-Score: N/A
  • GF Value™: €0.46 vs. price of €0.41 (10% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the FRA:8I8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrated Diagnostics Holdings Business Description

Other Exchanges IDGXF:USAIDHCl:UKIDHC:UK
Address 12 Castle Street, St Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
56GF Score

Get the complete analysis for FRA:8I8

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price
€0.46
GF Value